Cingulate Inc. (CING) Corporate Subsidiaries
Cingulate Inc. (CING) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CING
CIK: 1862150
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerAshlee Harmon
Audit LocationKansas City, Missouri, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-09-30 | 4 | 0001493152-26-045581 | View SEC Doc Filr Page |
| 8-K | 2026-10-02 | 2026-09-30 | 8-K | 0001493152-26-045527 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001493152-26-037606 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001493152-26-037605 | View SEC Doc Filr Page |
| 8-K | 2026-07-23 | 2026-07-17 | 8-K | 0001493152-26-034402 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | 4 | 0001493152-26-033972 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | 4 | 0001493152-26-033970 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | 4 | 0001493152-26-033968 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | 4 | 0001493152-26-033967 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | 4 | 0001493152-26-033964 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | 4 | 0001493152-26-033963 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | 4 | 0001493152-26-033961 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | 4 | 0001493152-26-033959 | View SEC Doc Filr Page |
| S-8 | 2026-07-15 | — | S-8 | 0001493152-26-033391 | View SEC Doc Filr Page |
| 8-K | 2026-07-14 | 2026-07-09 | 8-K | 0001493152-26-033115 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 | 0001493152-26-031983 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-06-30 | 8-K | 0001493152-26-031668 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-16 | 8-K | 0001493152-26-028815 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-02-13 | 4 | 0001493152-26-027794 | View SEC Doc Filr Page |
| 3 | 2026-06-08 | 2026-02-13 | 3 | 0001493152-26-027793 | View SEC Doc Filr Page |
| 8-K | 2026-06-02 | 2026-06-02 | 8-K | 0001493152-26-026760 | View SEC Doc Filr Page |
| DEF 14A | 2026-05-29 | 2026-05-29 | DEF 14A | 0001493152-26-025721 | View SEC Doc Filr Page |
| ARS | 2026-05-29 | 2025-12-31 | ARS | 0001493152-26-025727 | View SEC Doc Filr Page |
| DEFA14A | 2026-05-29 | — | DEFA14A | 0001493152-26-025725 | View SEC Doc Filr Page |
| 8-K | 2026-05-19 | 2026-05-18 | 8-K | 0001493152-26-024435 | View SEC Doc Filr Page |